Schizophrenia, Paranoid - 20 Studies Found
Completed |
: MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016) : Paranoid Schizophrenia : 2007-07-24 :
|
Completed |
: Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) :
: Drug: asenapine asenapine 2.5 mg or 5.0 mg sublingual tablets, administered BID |
Completed |
: Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) :
: |
Completed |
: MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027) :
: 2007-05-31 :
|
Completed |
: Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone :
|
Completed |
: Cognitive Determinants of Psychoeducation and Information in Psychoses :
: 2008-03-25 : Behavioral: COGPACK training, psychoeducation Bifocal psychoeducation group program (Munich Psychoses In |
Completed |
: Acceptance and Commitment Therapy for Delusions :
: 2008-04-08 : Behavioral: Acceptance and Commitment Therapy Considered part of the "third wave of CBT" along |
Completed |
: A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis :
|
Recruiting |
: D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions :
|